ARCHIVES

Minimally Invasive Radiation Said To Preserve Functions

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves

November 13, 1998

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

October 20, 2006

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014